Advertisement
Product › Details
gadofosveset trisodium (INN)
Next higher product group | contrast medium / imaging agent | |
Status | 2005-10-05 registration start | |
Organisation | Schering AG (FSE: SCH, NYSE: SHR) | |
Today | Bayer Schering Pharma AG | |
Group | Bayer (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for contrast medium / imaging agent
- [1] Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh....
- [2] Cosmo Pharmaceuticals N.V.. (7/28/17). "Press Release: Cosmo Half-Year Report 2017". Dublin....
- [3] Cosmo Pharmaceuticals N.V.. (7/26/17). "Press Release: Cosmo Announces European Approval of Qolotag for Sigmoidoscopies in IBD Patients". Dublin....
- [4] Cosmo Pharmaceuticals N.V.. (7/24/17). "Press Release: Cosmo Announces Submission to FDA of New Drug Application for LuMeBlue". Dublin....
- [5] Cosmo Pharmaceuticals N.V.. (3/27/17). "Press Release: Cosmo Announces further Expansion of Endoscopy Pipeline with Filing for EU Approval of New Medical Device Qolotag to Enhance Diagnosis in Sigmoidoscopies". Dublin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top